Neurotech is Humanity’s Next Frontier!
I’ve been investing in neurotech since 2021 and working with teams building BCIs, NeuroAI, and connectomics. It now feels like AI did in ~2019.
We are entering an extraordinary era: neurotech already restores functions, it can enhance our capabilities, and will evolve what it means to be human.
PLC Neurotech is the fund backing the extraordinary founders and defining companies of this booming industry.
In my ongoing quest to find the limits of Opus 5.5, I directed it to audit my old scientific field, theoretical astrophysics. We indexed about 150,000 papers, audited 50,000 for issues, and did progressively more thorough checks on thousands more. We found nearly 1000 major errors that got cited many times, most are still uncorrected. This survey enabled me to estimate the efficacy of peer review for correcting errors (not very good) and to identify dozens of open questions that anyone with spare Claude Max tokens could answer today (.md context files included).
Bottom line: AI can speed up quantitative science by >1000x with no further model improvement required. But I'm seeing no evidence of this being pushed within universities, only academics complaining about labs dropping math proofs.
Among my fellow reformed academic high agency founders, however, several are speed running entire disciplines.
This survey has implications for how science will be run in the very near future. Hint: Academic publishing is dead. It was already a very stupid way to record and promulgate knowledge, and had been so for decades, even before all that publicly funded knowledge was locked behind paywall cartels. Now AIs can generate thousands of novel, correct papers per day, it is no longer meaningful for humans to consider a research paper a "unit of science" or to even bother much with the 99.9% of science which, up to this point, was necessary drudgery. Time to discover something like General Relativity or Evolution every week. LFG!!
Enjoy: science.caseyhandmer.com/phy…
one of the things we were planning on doing with our Series D proceeds was sending an annoying amount of money to Nvidia
We’re pausing that for now to explore the state of AMD, Tenstorrent, and other emerging hardware
Used to be limited by cuda but Mythos changes things
Applications are open for Astera Residencies, now through January 7, 2027! Up to $2M in funding, based out of our Emeryville hub. This round, we’re sharing a few specific project requests. Read more and apply here: astera.org/residency/
Reshare with folks who should see this!
Selling Oculus to Facebook in 2014 gave me money for helicopter flight lessons and developing a seastead called SLAB with a 1,000 year design life.
The goal was to be cheaper than land and absent state/local laws that cripple critical American industries like metal processing, medical research/treatment, desalination, oil refining, chemical engineering, and more. Me and a few close friends cashed it up at a $1B valuation back in 2017, and while it still has a long way to go, there has been significant progress towards my goal of reviving manifest destiny and westward expansion. At a time when most of the seasteading community wanted to escape the US and smoke pot, this was the one project explicitly designed to make America stronger, a relief valve for ill considered or outdated rules and regulations.
I am only talking about it now because a few media outlets got wind of me and some friends topping up the coffers and plan on calling SLAB my new floating AI datacenter project. It is way cooler than that, way older than that, and I hate looking like a hype-chasing consensus loser, so now you have to read this tweet.
It took about a full week and a ridiculous number of Fable credits, but Claude figured out how to train a 6M parameter model that fits into 3.2 MB optimized for Game Boy. The result: on-cartridge generative conversation with a finch oddly knowledgeable about the Revolutionary War
@GordianBio is hiring a special agent for 1-3 mos,to work directly with me on a secret project with the utmost consequences for our ability to eliminate disease.
Need high agency and follow-through, familiarity with healthcare bonus but not required.
DM me.
AI in bio needs more data. But “more” isn’t a strategy. What data does AI need to accelerate longevity drugs?
Our founder @MartinBJensen is back in the arena today at Foresight Institute’s Vision Weekend USA in San Francisco, speaking on “Making AI Work for Longevity.”
He’ll be talking about how the data we generate determines where and when AI accelerates progress. New cures need physiological data from organs and organisms, and those experiments take months or years. We need to start generating that data now.
Event program: visionweekend.foresight.org/